DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021)" report to their offering.
The global market for breast cancer has grown swiftly over the past few years driven by introduction of several new drugs and biosimilars. The overall breast cancer market remained mainly dominated by the generic drugs. The future market for breast cancer will grow in the coming years as there exist unmet need for new drugs that would overcome resistance and prevent recurrence of the disease.
The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, clinical trials of CDK4/6 inhibitors and introduction of new imaging tests. However, growth of the market can be hindered by several factors including drug development challenges in developing countries, long term side effects of drugs and heavy costs associated with drug development.
The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche.
- Rising Consumption of Tobacco and Alcohol
- Increasing Global Diabetic Population
- Increasing Obesity
- Increasing Healthcare Expenditure Per Capita
- Rising Female Population Aged 65 Years & Above
- Global Spending on Medicines
Key Trends & Developments
- PARP Inhibitors under Development
- CDK4/6 Inhibitors Under Clinical Trials for Breast Cancer
- Introduction of Newer Imaging Tests
- Long Term Side Effects
- Drug Development Challenges in Developing Countries
- Heavy Drug Developmental Costs
Key Topics Covered:
2. Global Breast Cancer Market
3. Regional Breast Cancer Market
4. Market Dynamics
6. Company Profiles
- Johnson & Johnson
For more information about this report visit http://www.researchandmarkets.com/research/fcg54c/global_breast